Advertisement

Topics

Lilly Corporate Center Company Profile

12:43 EST 20th February 2017 | BioPortfolio

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of <!--LGfEGNT2Lhm-->protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of <!--LGfEGNT2Lhm-->Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.

 

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Mail Drop Code 1854
Indianapolis
Indiana
46285
United States of America

Contact

Phone: 317-276-2790
Fax: 317-276-4878


News Articles [1595 Associated News Articles listed on BioPortfolio]

Figure: Lilly's launch pad

Lilly's history lesson Lilly's launch pad During John Lechleiter's tenure as president and CEO Eli Lilly and Co. (NYSE:LLY) will have launched 10 drugs. Seven of these will be three years old or less,...

FDA delays decision on Lilly RA hopeful

US regulators are to delay a decision on Eli Lilly’s potential rheumatoid arthritis blockbuster, baricitinib, by three months in order to consider further information submitted by the manufacturer. ...

Lilly announces plan to expand global access to health care

Eli Lilly has announced a project, known as Lilly 30x30, which is a five-year, $90 million investment to improve access to treatments for diabetes, cancer and tuberculosis. read more

Eli Lilly's Fiscal 2016 Earnings: Analyzing The Surprising Results

Shares of pharmaceutical giant Eli Lilly rose 3% on Jan. 31, after the company reported better-than-expected financial results for the fourth quarter. Eli Lilly has had a difficult time over past few ...

Lilly Announces Series of Organizational and Leadership Changes

NewsLilly to adjust organization and leadership structure to better align with growth opportunities. Christi Shaw to return in April; Alex Azar, president of Lilly USA, out.

Lilly to Acquire CoLucid for $960 Million in Cash

INDIANAPOLIS and CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acqui...

Lilly rolls out insulin discount program

David SalazarEli Lilly & Co. has outlined a new initiative, set to begin Jan. 1, 2017, that will offer access to Lilly insulin at discounted prices to patients via Blink Health’s mobile and ...

Lilly’s new chief sets out plan for growth

David Ricks, soon to be the new chief executive of Eli Lilly, has set out a bullish forecast for the business over the next five years. Ricks is currently head of Lilly’s Bio-Medicines division, an...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Indiana Oxygen Company, Inc.]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

PubMed Articles [820 Associated PubMed Articles listed on BioPortfolio]

The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space.

Venturing into the immensity of the small molecule universe to identify novel chemical structure is a much discussed objective of many methods proposed by the chemoinformatics community. To this end n...

Opening a New Level II Trauma Center near an Established Level I Trauma Center: Is This Good for Trauma Care?

To describe how the initiation and later removal of a provisional level II trauma center (PL2TC) status at a community hospital affected the volume and severity of injured patients seen at an establis...

Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers?

Scientific Registry of Transplant Recipients(SRTR) report cards of US organ transplant center performance are publicly available and utilized for quality oversight. Low center performance(LP) evaluati...

Does a Standalone Cancer Center Improve Head and Neck Microsurgical Outcomes?

Objectives To evaluate the role of hospital setting (standalone cancer center vs. large multidisciplinary hospital) on free tissue transfer (FTT) outcomes for head and neck reconstruction. Methods...

Impact of the Use of Regional Poison Control Centers in an Urban EMS Dispatch System.

The public commonly calls 911 for unintentional ingestions, rather than calling the local poison center. By utilizing a series of scripted questions, 911 dispatchers in Los Angeles determine if an ing...

Clinical Trials [1343 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Lilly's Emotional and Physical Symptoms of Depression Study

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [1439 Associated Companies listed on BioPortfolio]

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

More Information about "Lilly Corporate Center" on BioPortfolio

We have published hundreds of Lilly Corporate Center news stories on BioPortfolio along with dozens of Lilly Corporate Center Clinical Trials and PubMed Articles about Lilly Corporate Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly Corporate Center Companies in our database. You can also find out about relevant Lilly Corporate Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record